Drawing for GPI

USPTO serial 79380171

GPI

Reviewed by CopyMark Law Group

Reg. 7726074Status 700Registered
Filing date
Status date
Registration date
Mar 18, 2025
Examiner
HUDSON, TAMARA BREE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GPI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Douglas M. McAllister

Douglas M. McAllister Lipsitz & McAllister, LLC755 Main Street, Building 8Monroe, CT 06468United States

Goods and services

ClassDescriptionStatusFirst use
041Educational instruction and teaching in the field of medicine, pharmaceuticals, healthcare, pharmaceutical delivery systems; training in the field of medicine, pharmaceuticals, healthcare, pharmaceutical delivery systems; publishing services, excluding printing, of books, e-books, periodicals; services of schools and universities, namely providing educational instruction in the field of medicine, pharmaceuticals, healthcare, pharmaceutical delivery systems; presentation of live spoken word performances, in particular on the Internet; publication of texts, excluding advertising texts; online provision of electronic non-downloadable publications in the nature of books, e-books, periodicals in the field of medicine, pharmaceuticals, healthcare, pharmaceutical delivery systems; online publication of electronic books and journals; arranging and conducting of conferences in the field of medicine, pharmaceuticals, healthcare, pharmaceutical delivery systems; arranging and conducting of congresses in the field of medicine, pharmaceuticals, healthcare, pharmaceutical delivery systems; arranging and conducting of symposia in the field of medicine, pharmaceuticals, healthcare, pharmaceutical delivery systems; personal training services; conducting of training courses in competency development; publication of printed matter, including in electronic form, other than for advertising purposes; publication of journals; arranging and conducting of seminars in the field of medicine, pharmaceuticals, healthcare, pharmaceutical delivery systems; arranging and conducting of training workshops in the field of medicine, pharmaceuticals, healthcare, pharmaceutical delivery systems; organization of exhibitions for educational purposes; publication of books; publication services, namely, publishing of books, e-books, periodicals; publication being publishing services, namely, publishing of books, e-books, periodicals; electronic publishing services of books, e-books, periodicals; multimedia publishing of electronic publications in the nature of books, e-books, periodicals; publication of magazine journals; publication of books, journals; publication being the publishing of books, e-books, periodicals; multimedia publishing of journals; multimedia publishing of magazines; providing electronic publications, namely, non-downloadable, in the nature of books, e-books, periodicals in the field of medicine, pharmaceuticals, healthcare, pharmaceutical delivery systems; micro-publishing of books, e-books, periodicals; publishing of printed matter; publishing of books and journals; online publication of electronic newspapers; publishing of books, e-books, periodicals; providing online non-downloadable publications in the nature of books, e-books, periodicals in the field of medicine, pharmaceuticals, healthcare, pharmaceutical delivery systems; online publication of books and journals; publishing services for the publication of magazines; providing non-downloadable electronic publications in the nature of books, e-books, periodicals in the field of medicine, pharmaceuticals, healthcare, pharmaceutical delivery systems; publisher services, including electronic publications, namely, publishing of books, e-books, periodicals; providing online-non-downloadable multimedia publications in the nature of books, e-books, periodicals in the field of medicine, pharmaceuticals, healthcare, pharmaceutical delivery systems; online publishing services for books, e-books, periodicals; electronic publication of texts and printed matter, excluding advertising texts, on the Internet; providing non-downloadable audio and visual media in the nature of spoken word via communication networks; providing non-downloadable electronic online publications in the nature of books, e-books, periodicals in the field of medicine, pharmaceuticals, healthcare, pharmaceutical delivery systems; conducting instructional courses in the field of medicine, pharmaceuticals, healthcare, pharmaceutical delivery systems; publication of journals and books in electronic form, also on the Internet; providing online, non-downloadable publications in the nature of books, e-books, periodicals in the field of medicine, pharmaceuticals, healthcare, pharmaceutical delivery systems; publication of online journals; publication of multimedia materials online; providing online reviews of books; conducting lectures relating to marketing skills; conducting training courses for strategic planning relating to advertising, promotion, marketing, research and development; conducting lectures relating to strategic planning regarding advertising, promotion, marketing, research and development; training in the field of pharmacy; adult education services being courses of instruction in the pharmaceutical field; arranging and conducting of lectures, in particular for educational purposes and training purposes in the field of medicine, pharmaceuticals, healthcare, pharmaceutical delivery systems; the aforementioned services not related to consultancy and treatment of paralysis in persons with mental illness; the aforementioned services not in the field of sociology, social science, peace and conflict resolution.ACTIVE—
042Scientific and technological services, namely, research and development in the field of pharmaceuticals and pharmaceutical delivery systems; medical and pharmaceutical research services; scientific research analysis; scientific research consultancy and advisory services; scientific research services; conducting scientific research investigations; provision of scientific information in the field of pharmaceuticals and pharmaceutical delivery systems; scientific research for the preparation of scientific reports; scientific and industrial research in the field of pharmaceuticals and pharmaceutical delivery systems; scientific research relating to oral delivery systems; consultancy relating to scientific research; providing scientific information in the field of pharmaceuticals and pharmaceutical delivery systems; scientific research for pharmaceutical purposes; conducting scientific research studies; pharmaceutic research and development; development and quality control review of pharmaceutical products; consultancy regarding pharmaceutical research and development; information technology services for the pharmaceutical and healthcare industries, namely on-site management of information technology (IT) systems of others; providing scientific information about the results of clinical trials for pharmaceutical products; providing online scientific information in the field of pharmacy; new product development in the field of formulations for medicinal products and pharmaceutical products; the aforementioned services not related to consultancy and treatment of paralysis in persons with mental illness.ACTIVE—
044Pharmaceutical advice; medical advisory services; providing online medical information in the field of pharmacy; pharmaceutical compounding services; medical pharmacy advice; providing medical information on pharmaceutical products; medical consultancy and information services relating to pharmaceutical products, also over the Internet; the aforementioned services not related to consultancy and treatment of paralysis in persons with mental illness.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 18, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 26, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 25, 2025FIMPFINAL DISPOSITION PROCESSED—
Jun 18, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 22, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 18, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 18, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 4, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 4, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jan 28, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 28, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 22, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 6, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 17, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 17, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 17, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Sep 11, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 11, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 11, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 30, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 30, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 30, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 27, 2024RFNTREFUSAL PROCESSED BY IB—
Feb 5, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 5, 2024RFRRREFUSAL PROCESSED BY MPU—
Jan 19, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 18, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 18, 2024DOCKASSIGNED TO EXAMINER—
Oct 19, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 19, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 19, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 19, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 19, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 10, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 6, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 5, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance